Registro:

Referencias:

• Cines, D., Pollak, E., Buck, C., Loscalzo, J., Zimmerman, G., McEver, R., Endothelial cells in physiology and in the pathophysiology of vascular disorders (1998) Blood, 91 (10), pp. 3527-3561
• Aird, W.C., Spatial and temporal dynamics of the endothelium (2005) J Thromb Haemost, 3, pp. 1392-1406
• Proceedings of the Third Margaux Conference on Critical Illness: The endothelium - an Underrecognized Organ in Critical Illness? Sedona, Arizona, USA. November 14-18, 2001. Crit Care Med 2002; 30 (5 Suppl): S179-348; Pober, J.S., Cotran, R.S., Cytokines and endothelial cell biology (1990) Physiol Rev, 70, pp. 427-451
• Reinhart, K., Bayer, O., Brunkhorst, F., Meisner, M., Markers of endothelial damage in organ dysfunction and sepsis (2002) Crit Care Med, 30 (5 SUPPL.), pp. S302-S312
• Kinasewitz G, Yan S, Basson B, Comp P, Russell J, Cariou A, et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism (ISRCTN 74215569). Crit Care 2004; 8 (2): R82-90; Duboscq, C., Porterie, P., Wainztein, N., Kordich, L., Interleukine and endothelial damage markers in septic patients (1999) Blood, 10 (SUPPL. 1). , Abst 3477
• Hack, C.E., Zeerleder, S., The endothelium in sepsis: Source of and a target of inflammation (2001) Crit Care Med, 29 (7 SUPPL.), pp. S21-S27
• Blann, A., Farrel, A., Picton, A., McCollum, C., Relation between andothelial cell markers and artherial stenosis in peripheral and carotid artery disease (2000) Thromb Res, 97, pp. 209-216
• Bonetti, P.O., Lerman, L., Lerman, A., Endothelial dysfunction: A marker of artherosclerotic risk (2003) Arterioscler Thromb Vasc Biol, 23, pp. 168-175
• Haire, W., Multiple organ dysfunction syndrome in hematopoietic stem cell transplantation (2002) Crit Care Med, 30 (5 SUPPL.), pp. S257-S267
• Duboscq, C., Bullorsky, E., Shanley, C., Stemmelin, G., Ceresetto, J., Rabinovich, O., Evaluación del daño endotelial en la enfermedad de injerto-contra-huésped (2001) Hematología, 5 (2), p. 165
• Quintana, I., Duboscq, C., Murúa, A., Galarza, C., Cámera, M., Kordich, L., High dermatan sulphate plasmatic levels in elderly individuals (1998) Br J Haematol, 102 (1), p. 357
• Upchurch, G., Welch, G., Loscalzo, J., Homocysteine, EDRF and endothelial function (1996) J Nutr, 126 (4 SUPPL.), pp. 1290S-12904
• Van Guldener, C., Stehouwer, C., Hyperhomocysteinemia vascular pathology and endotelial dysfunction (2000) Semin Thromb Hemost, 26 (3), pp. 281-289
• Ruoslahti, E., Specialization of tumor vasculature (2002) Nat Rev Cancer, 2, pp. 83-90
• St Croix, B., Rago, C., Velculescu, V., Traverso, G., Romans, K.E., Montgomery, E., Genes expressed in human tumor endothelium (2000) Science, 289, pp. 1197-1202
• Jacobson, S., Egberg, N., Hylander, B., Lundahl, J., Correlation between soluble markers of endothelial dysfunction in patients with renal failure (2002) Am J Nephrol, 22, pp. 42-47
• Gaenzer, H., Marschang, P., Sturn, W., Neumayr, G., Vogel, W., Patsch, J., Weiss, S.G., Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis (2002) J Am Coll Cardiol, 40, pp. 2189-2194
• Targonski, P., Bpnetti, P., Pumper, G., Higano, S., Holmes, D., Lerman, A., Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events (2003) Circulation, 107, pp. 2805-2809
• Cherian, P., Hankey, G., Eikelboom, J., Thom, J., Baker, R.I., McQuillan, A., Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes (2003) Stroke, 34, pp. 2132-2137
• Amar, J., Perez, L., Burcelin, R., Chamontin, B., Arteries, inflammation and insulin resistance (2006) J Hypertens Suppl, 24 (5), pp. S18-S20
• Mutunga, M., Fulton, B., Bullock, R., Batchelor, A., Gascoigne, A., Gillespie, J.I., Circulating endothelials cells in patients with septic shock (2001) Am J Respir Crit Care Med, 163 (1), pp. 195-200
• Boldt, J., Papsdorf, M., Rothe, A., Kumle, B., Piper, S., Changes of the hemostatic network in critically ill patients -Is there a difference between sepsis, trauma and neurosurgery patients? (2000) Crit Care Med, 28 (2), pp. 445-450
• Jy, W., Jimenez, J., Horstman, L., Mauro, L., Bidot, C., Yaniz, M., Microparticles derived from platelets (PMP), endothelial (EMP) and leukocytes (LMP) exhibit distinctive hemostatic and inflammatory activities (2005) Blood, 106 (11), p. 1029
• Quyyumi, A., Prognostic value of endothelial function (2003) Am J Cardiol, p. 91. , 12A, 19H-24H
• Aird, W., Endothelial cell heterogeneity (2003) Crit Care Med, 31 (4 SUPPL.), pp. S221-S230
• Aird, W.C., Endothelial cell dynamics and complexity theory (2002) Crit Care Med, 30 (5 SUPPL.), pp. S180-S185
• Page, C., Rose, M., Yacoub, M., Pigott, Antigenic heterogeneity of vascular endothelium (1992) Am J Pathol, 141, pp. 673-683
• Davies, P.F., Zilbelberg, J., Helmke, B., Spatial microestimul in-endothelial mechano signaling (2003) Circ Res, 92, pp. 359-370
• Rosenberg, R., Aird, W., Vascular-bed-specific hemostasis and hypercoagulable states (1999) N Engl J Med, 340 (20), pp. 1555-1564
• Zhu, D.Z., Cheng, C.F., Pauli, B.U., Mediation of lung metastasis of murine melanomas by a lung specific endothelial cell adhesion molecule (1991) Proc Natl Acad Sci USA, 88, pp. 9568-9572
• Milici, A.J., Furie, M.B., Carley, W.W., The formation of fenestrations and channels by capillary endothelium in vitro (1985) Proc Natl Acad Sci USA, 82, pp. 6181-6185
• Bombeli, T., Mueller, M., Haeberli, A., Anticoagulant properties of the vascular endothelium (1997) Thromb Haemost, 77 (3), pp. 408-423
• Gross, P.L., Aird, W.C., The endothelium and thrombosis (2000) Semin Thromb Haemost, 26 (5), pp. 463-478
• Mann, K.G., van't Veer, C., Cawthem, K., Butenas, S., The role of tissue factor pathway in initiation of coagulation (1998) Blood Coagul Fibrinolysis, 9 (SUPPL. 1), pp. S3-S7
• Franco, R.F., de Jonge, E., Dekkers, P.E., Timmerman, J.J., Spek, C.A., van Deventer, S.J., The in vivo kinectics of tissue factor messenger RNA expression during human endotoxemia: Relationship with activation of coagulation (2000) Blood, 96 (2), pp. 554-559
• Solovey, A., Solovey, A.N., Harkness, J., Hebbel, R.P., Modulation of endothelial cell activation in sickle cell disease: A pilot study (2001) Blood, 97, pp. 1937-1941
• Kataoka, H., Hamilton, J.R., McKemy, D.D., Camerer, E., Zheng, Y.W., Cheng, A., Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells (2003) Blood, 102 (9), pp. 3224-3231
• Jaffe, E.A., Hoyer, L.W., Nachman, R.L., Synthesis of von Willebrand factor by cultured human endothelial cells (1974) Proc Natl Acad Sci USA, 71, pp. 1906-1909. , STANDARDIZEDENDPARAG
• Blann, A.D., Plasma von Willebrand factor, thrombosis and the endothelium: The first 30 years (2006) Thromb Haemost, 5 (1), pp. 49-55
• Bourin, M., Lindahl, U., Glycosaminoglycans and the regulation of blood coagulation (1993) Biochem J, 289, pp. 313-330
• Esmon, C.T., The roles of protein C and thrombomodulin in the regulation of blood coagulation (1989) J Biol Chem, 264, pp. 4743-4746
• Moore, K., Esmon, C., Esmon, N., Tumor necrosis factor leads to internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture (1989) Blood, 73, pp. 159-165
• Duboscq, C., Lauricella, A., Kordich, L., Niveles de E- selectina y trombomodulina post oclusión venosa en individuos sanos (2001) Acta Bioquím Clín Latinoam, 2 (SUPL.), p. 114
• Broze, G., Tissue factor pathway inhibitor and the current concepto of blood coagulation (1995) Blood Coagul Fibrinolysis, 6 (SUPPL. 1), pp. S7-13
• Duboscq, C., (1997) El sistema fibrinolítico en pacientes sépticos, , Tesis doctoral. Universidad de Buenos Aires;
• Biemond, B.J., Levi, M., Ten Cate, H., der Poll, V., Buller, H.R., Hack, C.E., Plasminogen activator and plasminogen inhibitor 1 realese during experimental endotoxaemia in chimpanzees: Effect of interventions in the cytokine and coagulation cascades (1995) Clin Sci (Lond), 88 (5), pp. 587-594
• Sawdey MS, Loskutoff DJ. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor alpha, and transforming growth factor-beta. J Clin Invest 1991; 88: 1346.53; Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-73 [ STANDARDIZEDENDPARAG]; Comp P, Elrod J, Karzenski S. Warfarin-induced skin necrosis. Semin Thromb Hemost 1990; 16: 293-8; Isermann, B., Hendrickson, S.B., Zogg, M., Wing, M., Cummiskey, M., Kisanuki, Y.Y., Endothelium-specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and cause juvenile-onset thrombosis (2001) J Clin Invest, 108 (4), pp. 537-546
• Yanamoto, K., Lokustof, D., Fibrin deposition in tissues from endotoxin-treated mice correlates with decreased in the expression of urokinase type but not tissue type plasminogen activator (1996) J Clin Invest, 97 (11), pp. 2440-2451. , jun 1;

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------